| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | D16EQP0KKH |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-5 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Granulomatosis with Polyangiitis | 3 | D014890 | ClinicalTrials |
| Nasal Polyps | 3 | D009298 | ClinicalTrials |
| Hypereosinophilic Syndrome | 3 | D017681 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650469 |
| FDA SRS | D16EQP0KKH |
CONTENTS